Nav: Home

Scientific advances in thoracic oncology in 2016 highlighted by the IASLC

June 08, 2017

DENVER - Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2016, the International Association for the Study of Lung Cancer (IASLC) announces the second annual publication of "Scientific Advances in Thoracic Oncology," available online now and in the August 2017 issue of the IASLC's Journal of Thoracic Oncology (JTO).

Drawing on more than 41 multidisciplinary experts from around the globe, in different areas of lung cancer research and management, the IASLC introduces another valuable educational resource in order to keep busy practitioners, scientists and the general public up-to-date, with the latest information on non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) and mesothelioma.

"The pace of scientific advances in lung cancer is extremely rapid," said corresponding author Fred R. Hirsch, MD, PhD, Professor of Medicine and Pathology at the University of Colorado Cancer Center and School of Medicine and CEO of the IASLC. Dr. Hirsch also noted that, "The IASLC is uniquely poised to capture that progress and to help synthesize and disseminate critical information around the world."

These short and succinct summaries are designed to efficiently update the reader with the most influential and relevant facts regarding the topic in the past year. The publication's sources include large academic meetings such as the American Society of Clinical Oncology (ASCO), the IASLC World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology (ESMO); published literature; and novel, unpublished data from other international oncology assemblies.

This comprehensive article is divided into the following major categories:
    - Prevention and Early Detection

    - Pathology and Staging

    - Therapy (Surgery, Adjuvant Therapy, Radiotherapy, ALK, EGFR, ROS1 and other targeted therapies, Immunotherapy, Small Cell Lung Cancer, Mesothelioma and Quality and Value in Lung Cancer)

    - Specific Future Perspectives

"A very exciting time exists in the field of thoracic malignancies. In the past year, we have witnessed tremendous breakthroughs and advances in prevention and early detection, molecular diagnostics, pathology, staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy and immunotherapy. Important progress has been made in small cell lung cancer and malignant mesothelioma, all of which are included in this manuscript," said the editors Ross Soo, MBBS (National University Hospital, Singapore), and David Spigel, MD (Nashville, USA). "With more novel treatment options available, this manuscript reviews the quality and value of such therapy, and offers a perspective on emerging trends and future directions in lung cancer research and treatment."

Given the pace of advances in thoracic oncology, collecting and distributing up-to-date information is critical to improving outcomes worldwide. The IASLC is committed to serving as a global resource for all involved in thoracic oncology.
-end-
About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer. Founded in 1974, the association's membership includes more than 5,000 lung cancer specialists in over 100 countries. Visit http://www.iaslc.org for more information.

About the JTO

The Journal of Thoracic Oncology (JTO), the official journal of the IASLC, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. The JTO emphasizes a multidisciplinary approach and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. Visit http://www.jto.org for more information.

International Association for the Study of Lung Cancer

Related Lung Cancer Articles:

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.
Better equipped in the fight against lung cancer
Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women.
More Lung Cancer News and Lung Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...